Search research articles
Contact Us
Filters
Showing results (31-40 of 106) with videos related to
Page
of 11
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 3, 2009
Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report
Miho Murashima, Jill Adamski, Michael C Milone, et al.
Blood Advances
|
September 11, 2020
Stable HLA antibodies following sustained CD19+ cell depletion implicate a long-lived plasma cell source
Zheng Zhang, Stephen J Schuster, Simon F Lacey, et al.
The Journal of Cell Biology
|
June 6, 2012
F-actin polymerization and retrograde flow drive sustained PLCγ1 signaling during T cell activation
Alexander Babich, Shuixing Li, Roddy S O'Connor, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 21, 2025
Clinical advances in gene, cell, and RNA therapies
Michael C Milone, Jorge Mansilla-Soto, Norbert Pardi, et al.
Biochemical and Biophysical Research Communications
|
September 17, 2023
F77 antigen is a promising target for adoptive T cell therapy of prostate cancer
Payal Grover, Selene Nunez-Cruz, John Leferovich, et al.
Science Signaling
|
April 3, 2020
4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signaling
Benjamin I Philipson, Roddy S O'Connor, Michael J May, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 20, 2020
Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo
Sarah A Richman, Liang-Chuan Wang, Edmund K Moon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 23, 2020
Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo
Sarah A Richman, Liang-Chuan Wang, Edmund K Moon, et al.
Nature Cancer
|
February 5, 2022
Author Correction: Engineering-enhanced CAR T cells for improved cancer therapy
Michael C Milone, Jie Xu, Sai-Juan Chen, et al.
Nature Cancer
|
September 6, 2021
Engineering enhanced CAR T-cells for improved cancer therapy
Michael C Milone, Jie Xu, Sai-Juan Chen, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 106) with videos related to
Sort By:
Page
of 11
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 3, 2009
Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report
Miho Murashima, Jill Adamski, Michael C Milone, et al.
Blood Advances
|
September 11, 2020
Stable HLA antibodies following sustained CD19+ cell depletion implicate a long-lived plasma cell source
Zheng Zhang, Stephen J Schuster, Simon F Lacey, et al.
The Journal of Cell Biology
|
June 6, 2012
F-actin polymerization and retrograde flow drive sustained PLCγ1 signaling during T cell activation
Alexander Babich, Shuixing Li, Roddy S O'Connor, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 21, 2025
Clinical advances in gene, cell, and RNA therapies
Michael C Milone, Jorge Mansilla-Soto, Norbert Pardi, et al.
Biochemical and Biophysical Research Communications
|
September 17, 2023
F77 antigen is a promising target for adoptive T cell therapy of prostate cancer
Payal Grover, Selene Nunez-Cruz, John Leferovich, et al.
Science Signaling
|
April 3, 2020
4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signaling
Benjamin I Philipson, Roddy S O'Connor, Michael J May, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 20, 2020
Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo
Sarah A Richman, Liang-Chuan Wang, Edmund K Moon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 23, 2020
Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo
Sarah A Richman, Liang-Chuan Wang, Edmund K Moon, et al.
Nature Cancer
|
February 5, 2022
Author Correction: Engineering-enhanced CAR T cells for improved cancer therapy
Michael C Milone, Jie Xu, Sai-Juan Chen, et al.
Nature Cancer
|
September 6, 2021
Engineering enhanced CAR T-cells for improved cancer therapy
Michael C Milone, Jie Xu, Sai-Juan Chen, et al.
Page
of 11